Order Article Reprints

Deig CR, Sutton TL, Beneville B, Trone K, Stratton A, Gunesch AN, Liu AI, Alrohaibani A, Mohebnasab M, Bassale S, et al. Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications. Cancers. 2022; 14(3):609. https://doi.org/10.3390/cancers14030609

Deig, Christopher Ryan, Thomas Lee Sutton, Blake Beneville, Kristin Trone, Amanda Stratton, Ali N. Gunesch, Amy Ivy Liu, Alaaeddin Alrohaibani, Maedeh Mohebnasab, Solange Bassale, and et al. 2022. "Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications" Cancers 14, no. 3: 609. https://doi.org/10.3390/cancers14030609

Deig, C. R., Sutton, T. L., Beneville, B., Trone, K., Stratton, A., Gunesch, A. N., Liu, A. I., Alrohaibani, A., Mohebnasab, M., Bassale, S., Grossblatt-Wait, A., Keith, D., Attia, F., Gilbert, E. W., Lopez, C. D., Kardosh, A., Chen, E. Y., Bensch, K. G., Nabavizadeh, N., ... Grossberg, A. (2022). Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications. Cancers, 14(3), 609. https://doi.org/10.3390/cancers14030609